期刊文献+

液质联用法分析重组假丝酵母尿酸氧化酶的二硫键 被引量:2

Analysis of disulfide bond in recombinant Candida uricase by ultra-performance liquid chromatography-mass spectrometry
原文传递
导出
摘要 目的采用液质联用法分析重组假丝酵母尿酸氧化酶的二硫键数量及存在方式。方法将重组假丝酵母尿酸氧化酶分别进行烷基化及变性后烷基化处理,液质联用法测定未处理及两种不同方法处理后的尿酸氧化酶的平均相对分子质量,根据测定结果判断其二硫键数量及存在方式。结果未处理样品的平均相对分子质量为34 076.80,表明该蛋白以单体形式存在,不存在链间二硫键;直接烷基化样品平均相对分子质量为34 133.40,仅有一个游离巯基被烷基化;变性后烷基化样品的平均相对分子质量为34 304.80,4个游离巯基全被烷基化,蛋白不存在链内二硫键。结论重组假丝酵母尿酸氧化酶中的4个半胱氨酸未形成链间及链内二硫键。 Objective To analyze the number and pattern of disulfide bonds in recombinant Candida uricase by ultraperformance liquid chromatography-mass spectrometry(UPLC-MS). Methods Recombinant Candida uricase was alkylated directly and after denaturation respectively, and determined for mean relative molecular mass by UPLC-MS, using that untreated as control. The number and pattern were judged according to the determination result. Results The mean relative molecular mass of untreated uricase was 34 076. 80, indicating the protein as a monomer without inter-chain disulfide bond. However, only one free thiol group was alkylated in the directly alkylated sample with a mean relative molecular mass of 34 133. 40, while all the four free thiol groups were alkylated in the samples alkylated after dena-turation, with a mean relative molecular mass of 34 304. 80 and without intra-chain disulfide bond. Conclusion Neither inter- nor intra-chain disulfide bond was formed in recombinant Candida uricase.
出处 《中国生物制品学杂志》 CAS CSCD 2015年第7期746-748,共3页 Chinese Journal of Biologicals
基金 十二五科技重大专项"生物技术药物质量标准和质量控制技术平台"(2012ZX09304010)
关键词 液相色谱法 质谱法 假丝酵母 尿酸氧化酶 二硫键 Liquid chromatography Mass spectrometry Candida Uricase Disulfide bond
  • 相关文献

参考文献2

二级参考文献17

  • 1饶春明,陶磊,史新昌,杨英,韩春梅,裴德宁,王军志.重组人干扰素α1b质量肽图分析及二硫键定位[J].药物分析杂志,2007,27(10):1505-1510. 被引量:14
  • 2Sharma A,Krause A,Worgall S.Recent developments for Pseudomonas vaccines[J].Hum Vaccin,2011,7(10):999.
  • 3Dellagostin OA,Grassmann AA,Hartwig DD,et al.Recombinant vaccines against leptospirosis[J].Hum Vaccin,2011,7(11):1215.
  • 4Whitehead SS.Next-generation dengue vaccines: novel strategies currently under development[J].Viruses,2011,3(10):1800.
  • 5Kang SM,Song JM,Compans RW.Novel vaccines against influenza viruses[J]. Virus Res,2011,162(1-2):31.
  • 6Sharma A,Krause A,Worgall S.Recent developments for Pseudomonas vaccines[J].Hum Vaccin,2011,7(10): 999.
  • 7Li T,Lin H,Zhang Y,et al.Improved characteristics and protective efficacy in an animal model of E.coli-derived recombinant double-layered rotavirus virus-like particles[J].Vaccine,2014,32(17):1921.
  • 8Lua LH,Connors NK,Sainsbury F,et al.Bioengineering virus-like particles as vaccines[J].Biotechnol Bioeng,2014,111(3):425.
  • 9Rogeberg M,Furlund CB,Moe MK,et al.Identification of peptide products from enzymatic degradation of amyloid beta[J].Biochimie,2014.105:106.
  • 10Yin J,Shao C,Jia L,et al.Comparison at the peptide level with post-translational modification consideration reveals more differences between two unenriched samples[J].Rapid Commun Mass Spectrom,2014,28(12):1364.

共引文献10

同被引文献30

  • 1孟尧,辛渝,谭晓晶,许晓燕,余彩霞,杨波,孟延发.朊圆酵母尿酸酶的基本特性研究[J].四川大学学报(自然科学版),2006,43(2):414-419. 被引量:6
  • 2国家药典委员会.中国药典(三部)[s].北京:中国医药科技出版社,2010:111-114.
  • 3王军志.生物技术药物的研究开发和质量控制[M].北京:科学出版社,2007.
  • 4IGARASHI R,HOSHINO J,TAKENAGA M,et al.Lecithinization of superoxide dismutase potentiates its protective effect against forssman antiserum-induced elevation in guinea pig airway resistance[J].J Pharmacol Exp Ther,1992,262(3):1214-1219.
  • 5IGARASHI R,HOSHINO J,OCHIAI A,et al.Lecithinized superoxide dismutase enhances its pharmacologic potency by increasing its cell membrane affinity[J].J Pharmacol Exp Ther,1994,271(3):1672-1677.
  • 6UEMATSU T,NAGASHIMA S,UMEMURA K,et al.Pharmacokinetics and safety of intravenous recombinant human superoxide dismutase(NK341)in healthy subjects[J].Int J Clin Pharmacol Ther,1994,32(12):638-641.
  • 7BROEYER F J F,VAN AKEN B E,SUZUKI J,et al.The pharmacokinetics and effects of a long-acting preparation of superoxide dismutase(PC-SOD)in man[J].Br J Clin Pharmacol,2008,65(1):22-29.
  • 8SUZUKI J,BROEYER F,COHEN A,et al.Pharmacokinetics of PC-SOD,a lecithinized recombinant superoxide dismutase,after single-and multiple-dose administration to healthy Japanese and Caucasian volunteer[J].J Clin Pharmacol,2008,48(2):184-192.
  • 9LUO Q,CHUNG H H,BORTHS C,et al.Structural characterization of a monoclonal antibody-maytansinoid immunoconjugate[J].Anal Chem,2016,88(1):695-702.
  • 10GR NEWALD J,KLOCK H E,CELLITTI S E,et al.Efficient preparation of site-specific antibody-drug conjugates using phosphopantetheinyl transferases[J].Bioconjug Chem,2015,26(12):2554-2562.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部